Investors in Gritstone bio, Inc. Should Contact The Gross Law Firm Before August 6, 2024 to Discuss Your Rights – GRTS

Core Points - The Gross Law Firm has issued a notice to shareholders of Gritstone bio, Inc. regarding a class action lawsuit [1] - The class period for the lawsuit is from March 9, 2023, to February 29, 2024 [3] - Shareholders are encouraged to register for monitoring and updates related to the case, with a deadline to seek lead plaintiff status by August 6, 2024 [3][5] Allegations - The complaint alleges that Gritstone bio made materially false and misleading statements regarding its ability to launch the Phase 2b CORAL Study for its COVID-19 vaccine [6] - It is claimed that the company would be unable to launch the study within the timeframe previously communicated to investors [6] - The inability to launch the study is said to impair Gritstone's ability to secure external funding, negatively affecting its financial position [6] - The allegations suggest that Gritstone overstated its capability to develop and commercialize its products, leading to misleading public statements [6]